Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for rare, life-threatening genetic diseases. The company is headquartered in New York, New York. Show more

6555 CARNEGIE AVENUE, CLEVELAND, OH, UNITED STATES, 44103, Cleveland, OH, 44103, USA

https://www.abeonatherapeutics.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

412.6M

52 Wk Range

$4.00 - $7.54

Previous Close

$6.90

Open

$6.97

Volume

1,396,870

Day Range

$6.94 - $7.30

Enterprise Value

220.8M

Cash

61.37M

Avg Qtr Burn

-19.8M

Insider Ownership

16.54%

Institutional Own.

74.43%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ZEVASKYN™ (prademagene zamikeracel) Details Recessive dystrophic epidermolysis bullosa	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABO-102 (AAV-based Gene Therapy) Details Mucopolysaccharidosis type IIIA	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABO-503 (Gene Therapy) Details X-Linked Retinoschisis	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABO-701 (Engineered T-Cell Therapy) Details Advanced Prostate Cancer	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABO-101 (AAV-based Gene Therapy) Details Rare diseases, Rare genetic disease, Genetic disorder, Mucopolysaccharidoses, Mucopolysaccharidosis type IIIB	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.